APOA1 Protein

Produktnummer ABIN934456

Native APOA1-Protein exprimiert in Human und wurde in 1 Publikation erwähnt.

Kurzübersicht für APOA1 Protein (ABIN934456)

Target: APOA1 (Apolipoprotein A-I (APOA1))

Protein-Typ: Native

Spezies: Human

Quelle: Human

Reinheit: > 95 % pure

Produktdetails

Produktmerkmale: Purified native Human ApoA-I protein
Protein Source: Human plasma

Anwendungsinformationen

Applikationshinweise: Each Investigator should determine their own optimal working dilution for specific applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: Supplied in 10 mM NH0 CO3, pH 7.4.

Vorsichtsmaßnahmen: Donor samples were tested and found to be negative for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2. Nonetheless caution should be used when handling this material as there is a margin of error in all tests.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: -80 °C

Informationen zur Lagerung: Aliquot and store at -70 °C or lower.

Referenzen

Almiñana, Rudolf Vegas, Tekin, Hassan, Uzbekov, Fröhlich, Bollwein, Bauersachs: "Isolation and Characterization of Equine Uterine Extracellular Vesicles: A Comparative Methodological Study." in: International journal of molecular sciences, Vol. 22, Issue 2, (2021) (PubMed).

Antigendetails

Target: APOA1 (Apolipoprotein A-I (APOA1))

Andere Bezeichnung: ApoA-I

Hintergrund: 75 % of Apo A in HDL is Apo AI. Levels of Apo AI are inversely related to the risk of coronary heart disease. Apo AI is also thought to activate LCAT (lecithin cholesterol acyl tranferase). In normal plasma, Apo AI levels range from 90-130 mg per 100 ml.
Description: Human plasma.
Alternative Names: ApoA I protein, Apo AI protein, Apolipoprotein A-I protein, ApoA1 protein

Pathways: Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism